Filtered By:
Countries: Canada Health
This page shows you your search results in order of date. This is page number 16.
Order by Relevance | Date
Total 670 results found since Jan 2013.
Silicone allergy associated with intraocular silicone ball prosthesis in a dog
Can Vet J. 2021 Nov;62(11):1185-1189.ABSTRACTA 13-year-old, male Pomeranian dog was presented for scleral rupture with intraocular hemorrhage and retinal detachment in the right eye. After intrascleral silicone ball prosthesis, recurrent swelling and granulomatous blepharitis were observed for 140 d and finally melting keratitis developed. Although an intraorbital prosthesis was implanted, recurrent, serious, erosive, and ulcerative blepharitis developed with high plasma C-reactive protein concentrations. Since the blepharitis could not be controlled, the silicone ball was removed and the affected orbit was debrided. The b...
Source: The Canadian Veterinary Journal - November 3, 2021 Category: Veterinary Research Authors: Yuichiro Muramatsu Usio Fukushima Soroku Kudo Takumi Akatsuka Kenichiro Ono Hidehiro Hirao Source Type: research
New Analyses Suggest Favorable Results for STELARA ® (ustekinumab) When Used as a First-Line Therapy for Bio-Naïve Patients with Moderately to Severely Active Crohn’s Disease and Ulcerative Colitis
SPRING HOUSE, PENNSYLVANIA, October 25, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced data from two new analyses of STELARA® (ustekinumab) for the treatment of adults with moderately to severely active Crohn’s disease (CD) and ulcerative colitis (UC).1,2 In a modelled analysisa focused on treatment sequencing using data from randomized controlled trials, network meta-analysis and literature, results showed patient time spent in clinical remission or response was highest when STELARA was used as a first-line advanced therapy for bio-naïve patients with moderately to severely acti...
Source: Johnson and Johnson - October 25, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news
Separating Fact from Fiction in the Diagnosis and Management of Food Allergy
E.A. is an employee of Public Health Agency of Canada (PHAC). The views expressed in this article are her own and not that of PHAC. M.G. is is a consultant for Aquestive; is a member of physician/medical advisory boards for DBV Technologies, Sanofi/Regeneron, Genentech, Nutricia, Novartis, Acquestive, Allergy Therapeutics, Pfizer, ALK-Abello, US World Meds, Allergenis, Aravax, and Prota; is a member of the scientific advisory council for the National Peanut Board; is an associate editor for the Annals of Allergy, Asthma, and Immunology, and is member of the Joint Taskforce on Allergy Practice Parameters.
Source: The Journal of Pediatrics - October 19, 2021 Category: Pediatrics Authors: Elissa M. Abrams, Matthew Greenhawt, Marcus Shaker, Waleed Alqurashi Tags: Commentary Source Type: research
Vaccine allergy? Experts say most past reactions not valid reason for exemptions
Allergists across the country have safely inoculated most patients who come into their clinics, regardless of allergy history, says an Ontario doctor who's noticed an uptick in requests for allergy assessments after the government began implementing COVID-19 vaccine certificates last month.
Source: CBC | Health - October 17, 2021 Category: Consumer Health News Tags: News/Canada/Hamilton Source Type: news
